In neoplastic patients, an effective immune response ideally should be achieved by the coordinated action of different immune cells with tumor-suppressive functions. These include the more cytolytic members of the Innate Lymphoid Cells (ILCs) family represented by the Natural Killer (NK) cells, whose activities in cancer patients, however, can...
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2023 (v1)Publication
Simple Summary Children affected by high-risk tumors receive aggressive standard therapies that significantly improve their survival. Despite this, they have a low quality of life, suffer from life-threatening side effects, and a still-relevant number of them show resistance to therapy and develop fatal relapses. Immunotherapy showed exciting...
Uploaded on: February 7, 2024 -
2021 (v1)Publication
No description
Uploaded on: February 7, 2024 -
2022 (v1)Publication
Simple Summary Immunotherapies are emerging as promising strategies to cure cancer and extend patients' survival. Efforts should be focused, however, on the development of preclinical tools better able to predict the therapeutic benefits in individual patients. In this context, the availability of reliable preclinical models capable of...
Uploaded on: April 14, 2023 -
2018 (v1)Publication
The NK cells functions are finely tuned by several kinds of inhibitory and activating receptors, whose pattern of expression characterizes different NK subpopulations and varies with the cell activation status. MicroRNAs have an important role in tightly regulating the expression of NK receptors and, analogously, the expression of their ligands...
Uploaded on: April 14, 2023 -
2022 (v1)Publication
MicroRNAs are involved in the regulation of different functions in immune and non-immune cells. Here we show that miR-24-3p functionally interacts with FASLG mRNA and down-regulates its expression. This interaction occurs in human natural killer cells (NK), leading to the modulation of FasL surface expression. Moreover, miR-24-3p also modulates...
Uploaded on: February 14, 2024